MASTER SETTLEMENT AGREEMENTMaster Settlement Agreement • July 28th, 2017 • New Jersey
Contract Type FiledJuly 28th, 2017 JurisdictionThis Master Settlement Agreement, dated August 1, 2017 (the “Execution Date”), is entered into by and between (i) Daiichi Sankyo, Inc., Daiichi Sankyo U.S. Holdings, Inc., and Daiichi Sankyo Co., Ltd. (collectively, “Daiichi Sankyo”), (ii) Forest Laboratories, Inc., now known as Forest Laboratories, LLC, Forest Research Institute, Inc., and Forest Pharmaceuticals, Inc. (collectively, “Forest”), and (iii) the plaintiffs’ counsel listed in the signature pages hereto under the heading “Plaintiffs’ Negotiating Committee” (“PNC”). Daiichi Sankyo, Forest and the PNC have agreed to establish a private settlement program intended to resolve the claims of all persons who are eligible to enroll into the private settlement program, as set forth by the terms of this Agreement.
MASTER SETTLEMENT AGREEMENTMaster Settlement Agreement • July 28th, 2017 • New Jersey
Contract Type FiledJuly 28th, 2017 JurisdictionThis Master Settlement Agreement, dated August 1, 2017 (the “Execution Date”), is entered into by and between (i) Daiichi Sankyo, Inc., Daiichi Sankyo U.S. Holdings, Inc., and Daiichi Sankyo Co., Ltd. (collectively, “Daiichi Sankyo”), (ii) Forest Laboratories, Inc., now known as Forest Laboratories, LLC, Forest Research Institute, Inc., and Forest Pharmaceuticals, Inc. (collectively, “Forest”), and (iii) the plaintiffs’ counsel listed in the signature pages hereto under the heading “Plaintiffs’ Negotiating Committee” (“PNC”). Daiichi Sankyo, Forest and the PNC have agreed to establish a private settlement program intended to resolve the claims of all persons who are eligible to enroll into the private settlement program, as set forth by the terms of this Agreement.